[1]
S. A. Kale, MD, JD, MS and R. L. Barkin, PharmD, MBA, “Tactics of the physician-controlled counter—detail and the imminent risk of not changing pharma’s detail relationship with physicians”, J of Opioid Management, vol. 3, no. 5, pp. 239–241, Sep. 2007.